Company Details

Xi'an Henrikang Biotech Co.,Ltd [Shaanxi,China] Business Type: Manufacturer , Trade Company Main Markets: Africa , Americas , East Europe , Europe , Middle East , North Europe , West Europe , Worldwide Exporter: 81% - 90% Certs: ISO9001, API, CE Description: Raloxifene Vs Tamoxifen,Raloxifene Mechanism of Action,Raloxifene and Breast Cancer

Inquiry Basket ( 0 )

Select Language

English

Home > Products > Human APIs > Antimicrobial agents > breast cancer tamoxifen and Raloxifene mechanism of action

breast cancer tamoxifen and Raloxifene mechanism of action

Unit Price:	15~20 USD
Payment Type:	L/C,T/T,D/P,D/A
Incoterm:	FOB,CFR,CIF,EXW,FCA,CPT,CIP,FA
Min. Order:	1 Kilogram

 breast cancer tamoxifen and Raloxifene mechanism of action

Basic Info

Model No.: HRK-Raloxifene

Brand: Henrikang

Appearance: White Powder

Storage: Cool Dry Place

Shelf Life: 2 Years

Grade: Pharmaceutical Grade

Molecular Weight: 342.69

Molecular Formula: C28h28clno4s

CAS: 82640-04-8

Product Name: Hrk-Raloxifene

Active Ingredient: Raloxifene

Sample: Raloxifene Avaliable

Additional Info

Packaging: 1kg per bag. or customized packaging.

Productivity: 100000 kg

Transportation: Ocean,Land,Air,Express

Place of Origin: Shaanxi,China

Supply Ability: 600000 kg/months

Certificate: ISO

HS Code: N/A

Port: Shanghai,Qingdao,Guangzhou

Payment Type: L/C,T/T,D/P,D/A

Incoterm: FOB,CFR,CIF,EXW,FCA,CPT,CIP,FA

Product Description

breast cancer Tamoxifen and Raloxifene mechanism of action

Product Name:breast cancer tamoxifen and Raloxifene mechanism of action

CAS:82640-04-8
MF:C28h28clno4s

MW:342.69

Storage: 2 Years
Shelf Life : Cool Dry Place

What is Raloxifene

Raloxifene HCL is an oral selective estrogen receptor modulator (SERM) that has estrogenic actions on bone and anti-estrogenic actions on the uterus and breast. Raloxifene HCL is used in the prevention of osteoporosis in postmenopausal women.

Function of Raloxifene

Raloxifene HCL is also used to decrease the risk of developing invasive breast cancer (breast cancer that has spread outside of the milk ducts or lobules into the surrounding breast tissue) in women who are at high risk of developing this type of cancer or who have osteoporosis.

Raloxifene HCL cannot be used to treat invasive breast cancer or to prevent invasive breast cancer from coming back in women who have already had the condition.

Application of Raloxifene

Raloxifene Hydrochloride is an active pharmaceutical ingredient used to prevent osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast cancer.

Product Name

breast cancer tamoxifen and Raloxifene mechanism of action

specification

99%

certificate

ISO 9001

Keywords

Bulk Raloxifene , Raloxifene powder , pure Raloxifene

Test method

HPLC

Raloxifene

Xi'an Henrikang Biotech Co., Ltd., was established in May 2010, and located in Gaoling Industrial Park, Xi`an city, Shaanxi Province, China. It is a professional supplier of Healthcare Products, Vitamin And Enzyme, Human Apis, Cosmetic Raw, Veterinary Products, Food Additives, plant extract and natural active ingredients. It has absolute advantage because of strong research strength, modern management system and high-quality marketing team.

Now we have 3 GMP standard workshop, Meanwhile, the factory is equipped with the researching and quality inspection centre, with strong technology research and development strength. We also have 3 salesdepartments over 30 people and sell our products all over the world.

For customer`s needs, OEM service is also acceptable. If you have a good idea in new product production but lack of laboratory device and human resource, we are glad to solve this problem for you. Sincerely hope to strengthen exchanges and cooperation with friends from both home and abroad.